Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Swiss Cancer Institute
OHSU Knight Cancer Institute
University of Washington
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Northwestern University